$VRTX VERTEX PHARMACEUTICALS INC / MA Insider Trading Week 38/2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in VERTEX PHARMACEUTICALS INC / MA.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in VERTEX PHARMACEUTICALS INC / MA in week 38/2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 26 2014 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | Director | Option Exercise | M | 59.55 | 2,500 | 148,875 | 5,000 | |
| Sep 26 2014 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | Director | Sell | S | 109.75 | 2,500 | 274,375 | 0 | 2.5 K to 0 (-100.00 %) |
| Sep 26 2014 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | Director | Buy | M | 59.55 | 2,500 | 148,875 | 2,500 | 0 to 2.5 K |
| Sep 26 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Option Exercise | M | 11.27 | 5,200 | 58,604 | 5,700 | |
| Sep 26 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 111.69 | 800 | 89,352 | 338,895 | 339.7 K to 338.9 K (-0.24 %) |
| Sep 26 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 111.04 | 1,000 | 111,040 | 339,695 | 340.7 K to 339.7 K (-0.29 %) |
| Sep 26 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 109.71 | 1,000 | 109,710 | 340,695 | 341.7 K to 340.7 K (-0.29 %) |
| Sep 26 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 109.04 | 100 | 10,904 | 341,695 | 341.8 K to 341.7 K (-0.03 %) |
| Sep 26 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 108.57 | 500 | 54,285 | 341,795 | 342.3 K to 341.8 K (-0.15 %) |
| Sep 26 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 107.39 | 1,200 | 128,868 | 342,295 | 343.5 K to 342.3 K (-0.35 %) |
| Sep 26 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 106.25 | 600 | 63,750 | 343,495 | 344.1 K to 343.5 K (-0.17 %) |
| Sep 26 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Buy | M | 11.27 | 5,200 | 58,604 | 344,095 | 338.9 K to 344.1 K (+1.53 %) |
| Sep 23 2014 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Option Exercise | M | 45.11 | 10,125 | 456,739 | 16,875 | |
| Sep 23 2014 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Option Exercise | M | 48.74 | 3,375 | 164,498 | 9,000 | |
| Sep 23 2014 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Option Exercise | M | 37.86 | 3,375 | 127,778 | 6,750 | |
| Sep 23 2014 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Option Exercise | M | 51.75 | 3,375 | 174,656 | 4,500 | |
| Sep 23 2014 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Option Exercise | M | 38.80 | 2,813 | 109,144 | 1,875 | |
| Sep 23 2014 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Option Exercise | M | 33.82 | 1,407 | 47,585 | 0 | |
| Sep 23 2014 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Option Exercise | M | 39.05 | 938 | 36,629 | 0 | |
| Sep 23 2014 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Sell | S | 99.85 | 25,408 | 2,536,989 | 17,000 | 42.4 K to 17 K (-59.91 %) |
| Sep 23 2014 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Buy | M | 45.11 | 10,125 | 456,739 | 42,408 | 32.3 K to 42.4 K (+31.36 %) |
| Sep 23 2014 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Buy | M | 48.74 | 3,375 | 164,498 | 32,283 | 28.9 K to 32.3 K (+11.67 %) |
| Sep 23 2014 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Buy | M | 37.86 | 3,375 | 127,778 | 28,908 | 25.5 K to 28.9 K (+13.22 %) |
| Sep 23 2014 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Buy | M | 51.75 | 3,375 | 174,656 | 25,533 | 22.2 K to 25.5 K (+15.23 %) |
| Sep 23 2014 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Buy | M | 38.80 | 2,813 | 109,144 | 22,158 | 19.3 K to 22.2 K (+14.54 %) |
| Sep 23 2014 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Buy | M | 33.82 | 1,407 | 47,585 | 19,345 | 17.9 K to 19.3 K (+7.84 %) |
| Sep 23 2014 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Buy | M | 39.05 | 938 | 36,629 | 17,938 | 17 K to 17.9 K (+5.52 %) |
| Sep 23 2014 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Option Exercise | M | 45.11 | 25,500 | 1,150,305 | 65,125 | |
| Sep 23 2014 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Option Exercise | M | 53.74 | 27,000 | 1,450,980 | 45,500 | |
| Sep 23 2014 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 100.00 | 55,521 | 5,552,100 | 54,681 | 110.2 K to 54.7 K (-50.38 %) |
| Sep 23 2014 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Buy | M | 45.11 | 25,500 | 1,150,305 | 110,202 | 84.7 K to 110.2 K (+30.11 %) |
| Sep 23 2014 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Buy | M | 53.74 | 27,000 | 1,450,980 | 84,702 | 57.7 K to 84.7 K (+46.79 %) |
| Sep 23 2014 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | Director | Option Exercise | M | 59.55 | 5,000 | 297,750 | 7,500 | |
| Sep 23 2014 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | Director | Sell | S | 104.75 | 2,500 | 261,875 | 0 | 2.5 K to 0 (-100.00 %) |
| Sep 23 2014 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | Director | Sell | S | 99.75 | 2,500 | 249,375 | 2,500 | 5 K to 2.5 K (-50.00 %) |
| Sep 23 2014 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | Director | Buy | M | 59.55 | 5,000 | 297,750 | 5,000 | 0 to 5 K |